We would love to hear your thoughts about our site and services, please take our survey here.
Maybe HH an excellent start to a new year and to continue and re inforce the recent improvement on this bb would be to press the filter button on you know who. As stated by yourself he is unable to add any worthwhile contribution, and as you are aware seems to take pleasure in winding you up.
Jhfh, i sincerely hope youre correct, as a LTH i have a fair bit of skin in this game. Also invested in Sar who finally went clinical 6 months ago, coming towards the end of P1a soon, no issues but the SP has gone backwards, v perplexing.
Indeed, CBR at this stage is totally unquantifiable, could be many billions, another update due in the new year but lets face it, if Hemo develop an all encompassing viral treatment thats once in a lifetime Nobel prize winning stuff, an awful lot of hoops to get through 1st, so feet on the ground at present.
V interesting stuff HH, i note gracell had cash reserves of 230 million prior to the acquisition ! Their trial results were startlingly good and hard to ignore , im surprised gracell didnt hold out for a higher offer as they had plenty of funds to progress through trials on their own !